The details: BioAge began developing azelaprag as an anti-aging medication, because the expression of apelin tends to decrease as we get older one possible reason we lose muscle as we age
Because of that the dose, route of administration, and efficacy may differ from commercially available, brand-name, drugs
Free practical resources I created two companion resources to help turn this discussion into practical action
10.1152/ajpendo.00030.2002 [DOI] [PubMed] [Google Scholar] 162.Sturis J, Gotfredsen CF, Romer J, Rolin B, Ribel U, Brand CL, et al
[62] Viking Therapeutics (VK2735) VK2735 is a GLP1R/GIPR dual agonist, with a half-life of around 170-250 hours, undergoing both oral and subcutaneous injection clinical trials
Understanding IBS: Symptoms and Triggers Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder affecting approximately 10-20% of the UK population